Status:
COMPLETED
Central Sensitization and Alteration of Circulating Neurosteroid
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Arthroplasty, Replacement, Knee
Pain, Postoperative
Eligibility:
FEMALE
Up to 70 years
Brief Summary
For patients who underwent two-stage replacement of both knee joints (one knee surgery - one week term- the other knee surgery), postoperative pain and analgesic usage with patient-controlled analgesi...
Eligibility Criteria
Inclusion
- Two-staged bilateral total knee arthroplasty (one knee - one week - the other knee)
- American Society of Anesthesiologists (ASA) class I, II
- Postmenopausal women aged under 71
Exclusion
- Patients who have used analgesics before surgery, such as chronic pain patients
- ≥ ASA class III, including patients with renal impairment or symptomatic cardiovascular disease
- Patients who refuse to participate in the study or from whom receive informed consent cannot be received.
Key Trial Info
Start Date :
November 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2020
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03298711
Start Date
November 20 2017
End Date
May 6 2020
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620